ID   PLCD4_HUMAN             Reviewed;         762 AA.
AC   Q9BRC7; Q53FS8;
DT   02-OCT-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   10-MAY-2017, entry version 146.
DE   RecName: Full=1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-4;
DE            Short=hPLCD4;
DE            EC=3.1.4.11;
DE   AltName: Full=Phosphoinositide phospholipase C-delta-4;
DE   AltName: Full=Phospholipase C-delta-4;
DE            Short=PLC-delta-4;
GN   Name=PLCD4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, SUBCELLULAR
RP   LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=15140260; DOI=10.1186/1476-4598-3-15;
RA   Leung D.W., Tompkins C., Brewer J., Ball A., Coon M., Morris V.,
RA   Waggoner D., Singer J.W.;
RT   "Phospholipase C delta-4 overexpression upregulates ErbB1/2
RT   expression, Erk signaling pathway, and proliferation in MCF-7 cells.";
RL   Mol. Cancer 3:15-15(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Kidney proximal tubule;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   IDENTIFICATION.
RX   PubMed=10702683;
RA   Kim H., Suh P.-G., Ryu S.H., Park S.H.;
RT   "Assignment of the human PLC delta4 gene (PLCD4) to human chromosome
RT   band 2q35 by fluorescence in situ hybridization.";
RL   Cytogenet. Cell Genet. 87:254-255(1999).
RN   [5]
RP   TISSUE SPECIFICITY.
RX   PubMed=15505048; DOI=10.1167/iovs.04-0084;
RA   Landreville S., Coulombe S., Carrier P., Gelb M.H., Guerin S.L.,
RA   Salesse C.;
RT   "Expression of phospholipases A2 and C in human corneal epithelial
RT   cells.";
RL   Invest. Ophthalmol. Vis. Sci. 45:3997-4003(2004).
CC   -!- FUNCTION: Hydrolyzes the phosphatidylinositol 4,5-bisphosphate
CC       (PIP2) to generate 2 second messenger molecules diacylglycerol
CC       (DAG) and inositol 1,4,5-trisphosphate (IP3). DAG mediates the
CC       activation of protein kinase C (PKC), while IP3 releases Ca(2+)
CC       from intracellular stores. Required for acrosome reaction in sperm
CC       during fertilization, probably by acting as an important enzyme
CC       for intracellular Ca(2+) mobilization in the zona pellucida-
CC       induced acrosome reaction. May play a role in cell growth.
CC       Modulates the liver regeneration in cooperation with nuclear PKC.
CC       Overexpression up-regulates the Erk signaling pathway and
CC       proliferation. {ECO:0000269|PubMed:15140260}.
CC   -!- CATALYTIC ACTIVITY: 1-phosphatidyl-1D-myo-inositol 4,5-
CC       bisphosphate + H(2)O = 1D-myo-inositol 1,4,5-trisphosphate +
CC       diacylglycerol.
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108; Evidence={ECO:0000250};
CC       Note=Binds 3 Ca(2+) ions per subunit. Two of the Ca(2+) ions are
CC       bound to the C2 domain. {ECO:0000250};
CC   -!- SUBUNIT: Interacts with GRIP1. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250}; Peripheral membrane
CC       protein {ECO:0000250}. Nucleus {ECO:0000250}. Cytoplasm
CC       {ECO:0000269|PubMed:15140260}. Endoplasmic reticulum
CC       {ECO:0000250}. Note=Localizes primarily to intracellular membranes
CC       mostly to the endoplasmic reticulum.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9BRC7-1; Sequence=Displayed;
CC         Note=Acceptor splice site between exons 4 and 5 is non-canonical
CC         but conserved through species for that particular gene.;
CC       Name=2; Synonyms=PLCD4b;
CC         IsoId=Q9BRC7-2; Sequence=VSP_028501, VSP_028502;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay.;
CC   -!- TISSUE SPECIFICITY: Highly expressed in skeletal muscle and kidney
CC       tissues, and at moderate level in intestinal tissue. Expressed in
CC       corneal epithelial cells. {ECO:0000269|PubMed:15140260,
CC       ECO:0000269|PubMed:15505048}.
CC   -!- DOMAIN: The PDZ-binding motif mediates the interaction with GRIP1.
CC   -!- DOMAIN: The C2 domain mediates pre-localization to the membrane
CC       prior to Ca(2+) import and non-selective Ca(2+)-mediated targeting
CC       to various cellular membranes.
CC   -!- DOMAIN: The PH domain is not a critical determinant of the
CC       membrane localization.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY512961; AAS82574.1; -; mRNA.
DR   EMBL; AK223203; BAD96923.1; -; mRNA.
DR   EMBL; BC006355; AAH06355.1; -; mRNA.
DR   CCDS; CCDS46516.1; -. [Q9BRC7-1]
DR   RefSeq; NP_116115.1; NM_032726.3. [Q9BRC7-1]
DR   UniGene; Hs.632528; -.
DR   ProteinModelPortal; Q9BRC7; -.
DR   SMR; Q9BRC7; -.
DR   BioGrid; 124273; 3.
DR   IntAct; Q9BRC7; 4.
DR   MINT; MINT-1482361; -.
DR   STRING; 9606.ENSP00000388631; -.
DR   iPTMnet; Q9BRC7; -.
DR   PhosphoSitePlus; Q9BRC7; -.
DR   BioMuta; PLCD4; -.
DR   DMDM; 74732863; -.
DR   PaxDb; Q9BRC7; -.
DR   PeptideAtlas; Q9BRC7; -.
DR   PRIDE; Q9BRC7; -.
DR   DNASU; 84812; -.
DR   Ensembl; ENST00000417849; ENSP00000396942; ENSG00000115556. [Q9BRC7-1]
DR   Ensembl; ENST00000450993; ENSP00000388631; ENSG00000115556. [Q9BRC7-1]
DR   GeneID; 84812; -.
DR   KEGG; hsa:84812; -.
DR   UCSC; uc061smf.1; human. [Q9BRC7-1]
DR   CTD; 84812; -.
DR   DisGeNET; 84812; -.
DR   GeneCards; PLCD4; -.
DR   H-InvDB; HIX0002832; -.
DR   H-InvDB; HIX0030357; -.
DR   HGNC; HGNC:9062; PLCD4.
DR   HPA; CAB009914; -.
DR   HPA; HPA038139; -.
DR   HPA; HPA038140; -.
DR   MIM; 605939; gene.
DR   neXtProt; NX_Q9BRC7; -.
DR   OpenTargets; ENSG00000115556; -.
DR   PharmGKB; PA33390; -.
DR   eggNOG; KOG0169; Eukaryota.
DR   eggNOG; ENOG410XPSW; LUCA.
DR   GeneTree; ENSGT00760000118936; -.
DR   HOGENOM; HOG000006871; -.
DR   HOVERGEN; HBG053610; -.
DR   InParanoid; Q9BRC7; -.
DR   KO; K05857; -.
DR   PhylomeDB; Q9BRC7; -.
DR   TreeFam; TF313216; -.
DR   Reactome; R-HSA-1855204; Synthesis of IP3 and IP4 in the cytosol.
DR   SIGNOR; Q9BRC7; -.
DR   ChiTaRS; PLCD4; human.
DR   GeneWiki; PLCD4; -.
DR   GenomeRNAi; 84812; -.
DR   PRO; PR:Q9BRC7; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000115556; -.
DR   CleanEx; HS_PLCD4; -.
DR   ExpressionAtlas; Q9BRC7; baseline and differential.
DR   Genevisible; Q9BRC7; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0031965; C:nuclear membrane; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0004435; F:phosphatidylinositol phospholipase C activity; TAS:Reactome.
DR   GO; GO:0004871; F:signal transducer activity; IEA:UniProtKB-KW.
DR   GO; GO:0007340; P:acrosome reaction; IEA:Ensembl.
DR   GO; GO:0043647; P:inositol phosphate metabolic process; TAS:Reactome.
DR   GO; GO:0035556; P:intracellular signal transduction; IEA:InterPro.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0046488; P:phosphatidylinositol metabolic process; IEA:InterPro.
DR   CDD; cd00051; EFh; 1.
DR   Gene3D; 2.30.29.30; -; 1.
DR   Gene3D; 2.60.40.150; -; 1.
DR   Gene3D; 3.20.20.190; -; 1.
DR   InterPro; IPR000008; C2_dom.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR011993; PH_dom-like.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR001192; PI-PLC_fam.
DR   InterPro; IPR028387; PLC-delta4.
DR   InterPro; IPR017946; PLC-like_Pdiesterase_TIM-brl.
DR   InterPro; IPR015359; PLC_EF-hand-like.
DR   InterPro; IPR000909; PLipase_C_PInositol-sp_X_dom.
DR   InterPro; IPR001711; PLipase_C_Pinositol-sp_Y.
DR   PANTHER; PTHR10336; PTHR10336; 1.
DR   PANTHER; PTHR10336:SF120; PTHR10336:SF120; 1.
DR   Pfam; PF00168; C2; 1.
DR   Pfam; PF13202; EF-hand_5; 1.
DR   Pfam; PF09279; EF-hand_like; 1.
DR   Pfam; PF00169; PH; 1.
DR   Pfam; PF00388; PI-PLC-X; 1.
DR   Pfam; PF00387; PI-PLC-Y; 1.
DR   PRINTS; PR00390; PHPHLIPASEC.
DR   SMART; SM00239; C2; 1.
DR   SMART; SM00054; EFh; 3.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00148; PLCXc; 1.
DR   SMART; SM00149; PLCYc; 1.
DR   SUPFAM; SSF47473; SSF47473; 1.
DR   SUPFAM; SSF49562; SSF49562; 1.
DR   SUPFAM; SSF50729; SSF50729; 1.
DR   SUPFAM; SSF51695; SSF51695; 1.
DR   PROSITE; PS50004; C2; 1.
DR   PROSITE; PS00018; EF_HAND_1; 2.
DR   PROSITE; PS50222; EF_HAND_2; 3.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
DR   PROSITE; PS50007; PIPLC_X_DOMAIN; 1.
DR   PROSITE; PS50008; PIPLC_Y_DOMAIN; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Calcium; Complete proteome; Cytoplasm;
KW   Endoplasmic reticulum; Hydrolase; Lipid degradation; Lipid metabolism;
KW   Membrane; Metal-binding; Nucleus; Phosphoprotein; Reference proteome;
KW   Repeat; Transducer.
FT   CHAIN         1    762       1-phosphatidylinositol 4,5-bisphosphate
FT                                phosphodiesterase delta-4.
FT                                /FTId=PRO_0000306824.
FT   DOMAIN       16    124       PH. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00145}.
FT   DOMAIN      134    169       EF-hand 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   DOMAIN      170    205       EF-hand 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   DOMAIN      203    237       EF-hand 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   DOMAIN      290    435       PI-PLC X-box. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00270}.
FT   DOMAIN      493    609       PI-PLC Y-box. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00271}.
FT   DOMAIN      614    719       C2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00041}.
FT   CA_BIND     147    158       1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   CA_BIND     183    194       2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   REGION       26     53       Substrate binding. {ECO:0000250}.
FT   MOTIF       731    734       PDZ-binding.
FT   COMPBIAS    440    473       Glu-rich.
FT   COMPBIAS    479    486       Poly-Lys.
FT   ACT_SITE    305    305       {ECO:0000255|PROSITE-ProRule:PRU00270}.
FT   ACT_SITE    350    350       {ECO:0000255|PROSITE-ProRule:PRU00270}.
FT   METAL       306    306       Calcium 1; catalytic. {ECO:0000250}.
FT   METAL       335    335       Calcium 1; catalytic. {ECO:0000250}.
FT   METAL       337    337       Calcium 1; catalytic. {ECO:0000250}.
FT   METAL       384    384       Calcium 1; catalytic. {ECO:0000250}.
FT   METAL       650    650       Calcium 2; via carbonyl oxygen.
FT                                {ECO:0000250}.
FT   METAL       652    652       Calcium 2. {ECO:0000250}.
FT   METAL       676    676       Calcium 2. {ECO:0000250}.
FT   METAL       705    705       Calcium 3. {ECO:0000250}.
FT   METAL       706    706       Calcium 3; via carbonyl oxygen.
FT                                {ECO:0000250}.
FT   METAL       707    707       Calcium 3. {ECO:0000250}.
FT   BINDING     433    433       Substrate. {ECO:0000250}.
FT   BINDING     435    435       Substrate. {ECO:0000250}.
FT   BINDING     522    522       Substrate. {ECO:0000250}.
FT   BINDING     549    549       Substrate. {ECO:0000250}.
FT   MOD_RES     457    457       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q62711}.
FT   VAR_SEQ     259    272       KLRHVLSMDGFLSY -> ASEEDPGEGEEVNT (in
FT                                isoform 2).
FT                                {ECO:0000303|PubMed:15140260}.
FT                                /FTId=VSP_028501.
FT   VAR_SEQ     273    762       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15140260}.
FT                                /FTId=VSP_028502.
FT   CONFLICT     98     98       R -> H (in Ref. 2; BAD96923).
FT                                {ECO:0000305}.
SQ   SEQUENCE   762 AA;  87585 MW;  5444BE5CE2AEA3EF CRC64;
     MASLLQDQLT TDQDLLLMQE GMPMRKVRSK SWKKLRYFRL QNDGMTVWHA RQARGSAKPS
     FSISDVETIR NGHDSELLRS LAEELPLEQG FTIVFHGRRS NLDLMANSVE EAQIWMRGLQ
     LLVDLVTSMD HQERLDQWLS DWFQRGDKNQ DGKMSFQEVQ RLLHLMNVEM DQEYAFSLFQ
     AADTSQSGTL EGEEFVQFYK ALTKRAEVQE LFESFSADGQ KLTLLEFLDF LQEEQKERDC
     TSELALELID RYEPSDSGKL RHVLSMDGFL SYLCSKDGDI FNPACLPIYQ DMTQPLNHYF
     ICSSHNTYLV GDQLCGQSSV EGYIRALKRG CRCVEVDVWD GPSGEPVVYH GHTLTSRILF
     KDVVATVAQY AFQTSDYPVI LSLETHCSWE QQQTMARHLT EILGEQLLST TLDGVLPTQL
     PSPEELRRKI LVKGKKLTLE EDLEYEEEEA EPELEESELA LESQFETEPE PQEQNLQNKD
     KKKKSKPILC PALSSLVIYL KSVSFRSFTH SKEHYHFYEI SSFSETKAKR LIKEAGNEFV
     QHNTWQLSRV YPSGLRTDSS NYNPQELWNA GCQMVAMNMQ TAGLEMDICD GHFRQNGGCG
     YVLKPDFLRD IQSSFHPEKP ISPFKAQTLL IQVISGQQLP KVDKTKEGSI VDPLVKVQIF
     GVRLDTARQE TNYVENNGFN PYWGQTLCFR VLVPELAMLR FVVMDYDWKS RNDFIGQYTL
     PWTCMQQGYR HIHLLSKDGI SLRPASIFVY ICIQEGLEGD ES
//
